Table 1 Cellular processes affected by the deregulated genes induced by HPV E1 proteins. p-value ≤ 0.05.
HPV16 E1 | HPV18 E1 | HPV11 E1 | |||
|---|---|---|---|---|---|
Cellular process | % terms per group | Cellular process | % terms per group | Cellular process | % terms per group |
Regulation of peptidyl-tyrosine phosfhorylation | 27.78%** | Endothelial cell chemotaxis | 29.95%** | Regulation of MHC class I biosynthetic process | 31.82%** |
Formation of primary germ layer | 16.67%** | Negative regulation of viral genome replication | 18.42%** | Melanosome localization | 27.73%** |
Cellular response to vascular endothelial growth factor stimulus | 16.67** | Negative regulation of viral genome transcription | 15.79%** | MDA-5 signaling pathway | 13.64%** |
Negative regulation of viral genome replication | 16.67** | Positive regulation of epidermal cell differentiation | 13.16%** | Regulation of natural killer cell chemotaxis | 11.36%* |
Defense response to virus | 5.56%** | Regulation of toll-like receptor 9 signaling pathway | 7.89%** | Viral genome replication | 11.36%** |
Cellular response to interferon-gamma | 5.56%** | Monocyte differentation | 5.26%** | Type I interferon signaling pathway | 4.55%** |
Cytokine-mediated signaling pathway | 5.56%** | MDA-5 signaling pathway | 5.26%** | Pharyngeal system development | 2.27%* |
Regulation of bone mineralization | 5.56%** | Cellular response to corticotropin-releasing hormone stimulus | 2.63%** | Bile acid and bile salt transport 2.27%* | 2.27%* |
Response to corticosterone | 2.63%** | ||||